(Q43871288)

English

Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.

scientific article published in August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Paola Di Benedetto

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Roberto Giacomelli

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Vasiliki Liakouli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Beatrice Del Papa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Monica Di Padova

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

M Di Ianni

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Marrelli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E Alesse

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

173

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

195-206

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23607751%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Why are MSCs therapeutic? New data: new insight.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Mesenchymal stem cells can be differentiated into endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Immunomodulatory properties and therapeutic application of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Immunomodulatory properties of mesenchymal stromal cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

B cells in systemic sclerosis: a possible target for therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Immunosuppressive properties of mesenchymal stem cells: advances and applications.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Inflammatory markers in population studies of aging

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

The Ki-67 protein: from the known and the unknown

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

The aging effect of chemotherapy on cultured human mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Regulation generation: the suppressive functions of human regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Therapeutic potential of Tregs to treat rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Human regulatory T cells: role in autoimmune disease and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Modulation of graft-versus-host disease: role of regulatory T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Blinded by the Light: The Growing Complexity of p53

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Modes of p53 regulation

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

A dual role of p21 in stem cell aging.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

p53 and stem cells: new developments and new concerns

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Oxidative stress induces senescence in human mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

TGF-beta expression by allogeneic bone marrow stromal cells ameliorates diabetes in NOD mice through modulating the distribution of CD4+ T cell subsets

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

CD69 is an immunoregulatory molecule induced following activation

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

T regulatory cell separation for clinical application.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Aging and replicative senescence have related effects on human stem and progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722920

29 September 2018

Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-β

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12111

21 January 2018

Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722920

3 November 2018

Expression of transforming growth factor type beta on human epidermal dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated serum level of interleukin-10 in patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The suppressive effect of mesenchymal stromal cells on T cell proliferation is conserved in old age

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43871288&oldid=2149978463"